Delinking the cost of R&D from the final prices of medicines and making governments the funders and planners of drug development would be rife with problems.
February 2, 2016
Innovation Fact of the Week: US Leads World in Period of Data Exclusivity For Biologic Medicine Innovators
The United States leads the world in the period of data exclusivity it provides to innovators of biologic medicines, writes Adams Nager in Innovation Files.
January 28, 2016
Innovation Fact of the Week: IP Protections Spur Innovation, Contribute to Better Health Outcomes in Developing Nations
Stronger global intellectual property protection, such as the agreement on Trade-Related Aspects of Intellectual Property (TRIPS), which was signed in 1994, has helped spur innovation in health care and contributed to better health outcomes, writes John Wu in Innovation Files.
December 21, 2015
From alarmists touting an artificial intelligence apocalypse to activists fighting against genetically improved foods, this report highlights 10 of the year’s most egregious cases of neo-Luddism in action.
December 8, 2015
While many parts of the Trans-Pacific Partnership agreement will positively impact bio innovation, others will inhibit the development of the next generation of breakthrough medicines, said Stephen Ezell in testimony before the House Ways and Means Committee Democratic Members.
November 5, 2015
In comments to the White House Office of Science and Technology Policy, ITIF's Val Giddings argues there is no relationship between the degree of regulatory scrutiny a biotechnology product receives and the degree of hazard it represents.
June 22, 2015
A new paper shows that innovative treatments are adding years to cancer patients' lives.
April 16, 2015
Turkey's leaders need to create a more supportive environment for trade, investment, and innovation.
April 9, 2015
New research shows the value of medical innovation is much higher than previously estimated.
March 17, 2015
How Canada is killing innovation in its pharmaceutical industry.
March 16, 2015
Smart regulatory reform focused on sectors that compete internationally can boost U.S. economic competitiveness while maintaining, or even increasing, social benefits.